An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer. (Q43264871)
Jump to navigation
Jump to search
scientific article published on 8 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer. |
scientific article published on 8 October 2009 |
Statements
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer (English)
J Chang
S-C Chen
K Cwiertka
G Jerusalem
Z Jiang
S Johnston
B Kaufman
J Link
J Ro
J Schütte
C Oliva
R Parikh
A Preston
J Rosenlund
M Selzer
D Zembryki